FLASCO


 
 

Corporate Members

Diamond Elite

Diamond

Platinum

Gold

Silver

Latest News

incyte

National Treatment Guidelines for Myeloproliferative Neoplasms

Posted February 24, 2017

lncyte Corporation is pleased to announce that ruxolitinib (Jakafi®) has been included as a recommended treatment for myelofibrosis in the new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Myeloproliferative Neoplasms (MPNs). Myelofibrosis is a rare bone marrow cancer. Ruxolitinib (Jakafi®) is the first and only therapy that is FDA approved for patients with...

Walgreens Designates more than 50 Specialty Pharmacies as Cancer-Specialized Locations

Posted February 24, 2017

Collaborations with The Leukemia & Lymphoma Society, Oncology Nursing Society and others provide cancer-focused continuing education for Walgreens specialty pharmacy staff DEERFIELD, Ill – Feb. 22, 2017 – Furthering its commitment to personalized patient care and continuing education for its pharmacy staff, Walgreens has designated more than 50 of its local specialty pharmacies as cancer-specialized...

FDA Expands Indication for REVLIMID® (lenalidomide) as a Maintenance Treatment for Patients with Multiple Myeloma Following Autologous Hematopoietic Stem Cell Transplant (auto-HSCT)

Posted February 23, 2017

On February 22, 2017, the U.S. Food and Drug Administration approved lenalidomide (Revlimid®, Celgene Corp.) as maintenance therapy for patients with multiple myeloma following autologous stem cell transplant. In 2006, lenalidomide, an orally administered thalidomide analogue, received FDA approval for use with dexamethasone in patients with multiple myeloma who received at least one prior therapy....

Support SB 528/ SB 530 by Senator Steube – FAIL FIRST/STEP THERAPY

Posted February 20, 2017

While health insurance utilization management (restrictions on access) procedures such as fail first/step therapy may be appropriate measures to control costs, they have also been over-utilized under the cloak of confusion surrounding health care and to the detriment of numerous patients across Florida. Contact your legislator today to let them know, ultimately, healthcare professionals, not...

Who’s Online

There are no users currently online